Dabomb Protein (6578) — Capital Reinvestment Ratio
Latest as of March 2025:
2.53x
Dabomb Protein (6578) has a Capital Reinvestment Ratio of 2.53x as of March 2025, meaning it reinvests 3% of its operating cash flow (NT$8.12 Million) in capital expenditures (NT$20.59 Million). See 6578 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.53x
Capex / Operating Cash Flow
Operating Cash Flow
NT$8.12 Million
TWD
Capital Expenditures
NT$20.59 Million
TWD
Data as of
Mar 2025
Most recent filing
Dabomb Protein Capital Reinvestment Ratio (2015–2025)
This chart tracks Dabomb Protein's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Dabomb Protein (2015–2025)
Year-by-year Capital Reinvestment Ratio for Dabomb Protein from 2015 to 2025. For live market cap and broader valuation context, see Dabomb Protein stock valuation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.26x | NT$16.65 Million | NT$37.69 Million | ▲ +255.1% |
| 2024 | 0.64x | NT$47.55 Million | NT$30.32 Million | ▼ -78.0% |
| 2023 | 2.90x | NT$6.51 Million | NT$18.87 Million | ▲ +183.6% |
| 2022 | 1.02x | NT$19.71 Million | NT$20.16 Million | ▼ -25.1% |
| 2020 | 1.37x | NT$13.41 Million | NT$18.31 Million | ▼ -50.5% |
| 2019 | 2.76x | NT$33.26 Million | NT$91.81 Million | ▼ -62.6% |
| 2018 | 7.39x | NT$22.07 Million | NT$163.06 Million | ▲ +94.7% |
| 2017 | 3.79x | NT$43.87 Million | NT$166.46 Million | ▲ +143.9% |
| 2016 | 1.56x | NT$59.58 Million | NT$92.71 Million | ▲ +3977.6% |
| 2015 | 0.04x | NT$139.78 Million | NT$5.33 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow